US 11547759
Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
granted A61KA61K47/55A61P
Quick answer
US patent 11547759 (Bi-functional compounds and methods for targeted ubiquitination of androgen receptor) held by Montelino Therapeutics Inc. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Montelino Therapeutics Inc.
- Grant date
- Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/55, A61P, A61P35/00